CRISPR-Cas12a primer group for detecting vibrio cholerae and application of CRISPR-Cas12a primer group
Through the design of CRISPR-Cas12a primer set and specific target sequence, combined with CRISPR technology, the time-consuming and labor-intensive detection of Vibrio cholerae is solved, and fast and highly sensitive detection is achieved, suitable for on-site diagnosis, reducing detection costs and equipment dependence.
Patent Information
- Application Number
- CN202410807771.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-06-21
- Publication Date
- 2024-11-08
AI Technical Summary
The existing Vibrio cholerae detection methods are time-consuming and labor-intensive, inefficient, require professional personnel and expensive instruments, and have a high false positive rate, which is not suitable for on-site rapid testing.
Provides CRISPR-Cas12a primer sets for Vibrio cholerae and their applications. By designing specific target sequences and crRNA, combining CRISPR technology for gene detection, using fluorescent signals to achieve rapid and highly sensitive detection without complex temperature control, Laboratory large instruments depend on.
It achieves rapid, high sensitivity, strong specificity, short detection time, low cost, and convenient operation. It can be performed in an environment of 37-40℃, which is suitable for on-site diagnosis.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of biotechnology, and in particular relates to a CRISPR-Cas12a primer set for detecting Vibrio cholerae and an application thereof. Background Art
[0002] Vibrio cholerae (Burkholderia mallei) is a Gram-negative bacterium belonging to the genus Vibrio. It is widely found in shrimp, crab, oyster and other crustaceans and shellfish aquatic animals. It can cause cholera, a severe intestinal infectious disease. It has an acute onset, strong infectiousness and high mortality rate. It has caused many pandemics in the world and is a foodborne pathogen that is extremely harmful to humans. Although water quality, hygiene and clinical treatment of cholera have improved, the disease still causes about 100,000 deaths worldwide each year. Therefore, the rapid and efficient detection of Vibrio cholerae is of great significance in public health and epidemic prevention.
[0003] Classic Vibrio cholerae detection methods include isolation and culture, PCR technology, whole genome and metagenomic sequencing, etc. Although these methods play an important role in detecting Vibrio cholerae, they are time-consuming and labor-intensive, have a long time cycle and low efficiency, require professionals and expensive equipment, have a high false positive rate, and are not suitable for rapid on-site detection. Therefore, whether for prevention or treatment, it is necessary to develop a rapid, sensitive and specific method to detect Vibrio cholerae. Summary of the invention
[0004] The technical problem to be solved by the present invention is how to accurately and quickly detect Vibrio cholerae and / or how to quickly, highly sensitively and specifically detect Vibrio cholerae.
[0005] In order to solve the above technical problems, the present invention first provides a kit for detecting Vibrio cholerae, wherein the kit can be kit A, kit B or kit C;
[0006] The kit A may contain an ompw-3F / ompw-1R primer pair, a ctxa-2F / ctxa-1R primer pair, a Probe, an ompw-crRNA10 and a ctxa-crRNA3; the ompw-3F / ompw-1R primer pair is composed of an ompw-3F primer and an ompw-1R primer, the ompw-3F primer is a single-stranded DNA molecule shown in SEQ ID No.5 in the sequence list, and the ompw-1R primer is a single-stranded DNA molecule shown in SEQ ID No.7 in the sequence list; the ctxa-2F / ctxa-1R primer pair is composed of a ctxa-2F primer and a ctxa-1R primer, the ctxa-2F primer is a single-stranded DNA molecule shown in SEQ ID No.12 in the sequence list, and the ctxa-1R primer is a single-stranded DNA molecule shown in SEQ ID No.15 in the sequence list; the Probe is SEQ The single-stranded DNA molecule shown in SEQ ID No.42, the ompw-crRNA10 is the RNA molecule shown in SEQ ID No.40 in the sequence list, and the ctxa-crRNA3 is the RNA molecule shown in SEQ ID No.23 in the sequence list.
[0007] The kit B may contain an ompw-3F / ompw-1R primer pair, a Probe and an ompw-crRNA10; the ompw-3F / ompw-1R primer pair is composed of an ompw-3F primer and an ompw-1R primer, the ompw-3F primer is a single-stranded DNA molecule shown in SEQ ID No.5 in the sequence list, and the ompw-1R primer is a single-stranded DNA molecule shown in SEQ ID No.7 in the sequence list; the Probe is a single-stranded DNA molecule shown in SEQ ID No.42 in the sequence list, and the ompw-crRNA10 is an RNA molecule shown in SEQ ID No.40 in the sequence list.
[0008] The kit C may contain a ctxa-2F / ctxa-1R primer pair, a Probe and a ctxa-crRNA3; the ctxa-2F / ctxa-1R primer pair consists of a ctxa-2F primer and a ctxa-1R primer, the ctxa-2F primer is a single-stranded DNA molecule shown in SEQ ID No.12 in the sequence list, and the ctxa-1R primer is a single-stranded DNA molecule shown in SEQ ID No.15 in the sequence list; the Probe is a single-stranded DNA molecule shown in SEQ ID No.42 in the sequence list, and the ctxa-crRNA3 is an RNA molecule shown in SEQ ID No.23 in the sequence list.
[0009] In the kit described above, the Probe can be labeled with a fluorescent group on the 1st nucleotide of SEQ ID No.42, and a quenching group BHQ1 on the 12th nucleotide.
[0010] The kit described above may also contain Cas12a protein.
[0011] The above-mentioned kit may further include a recombinant vector containing the ompw gene sequence whose nucleotide sequence is SEQ ID No.1 and / or a recombinant vector containing the ctxa gene sequence whose nucleotide sequence is SEQ ID No.2.
[0012] In the above kit, the ompw-crRNA10 may be composed of a guide sequence and an anchor sequence; the guide sequence may be nucleotides 22-42 of SEQ ID No.40 in the sequence list; the anchor sequence may be nucleotides 1-21 of SEQ ID No.26 in the sequence list. The ctxa-crRNA3 may be composed of a guide sequence and an anchor sequence; the guide sequence may be nucleotides 22-41 of SEQ ID No.23 in the sequence list; the anchor sequence may be nucleotides 1-21 of SEQ ID No.23 in the sequence list.
[0013] The above-mentioned kit may further contain an RNase inhibitor.
[0014] In order to solve the above technical problems, the present invention also provides a system for detecting genomic DNA of Vibrio cholerae, and the system may contain the kit described above.
[0015] The above system may also contain a fluorescence detection system.
[0016] In order to solve the above technical problems, the present invention further provides a composition, which may be composition A-1, composition B-1 or composition C-1.
[0017] The composition A-1 may contain the above-mentioned ompw-3F / ompw-1R primer pair, ctxa-2F / ctxa-1R primer pair, Probe, ompw-crRNA10 and ctxa-crRNA3;
[0018] The composition B-1 may contain the above-mentioned ompw-3F / ompw-1R primer pair, Probe and ompw-crRNA10;
[0019] The composition C-1 may contain the ctxa-2F / ctxa-1R primer pair, Probe and ctxa-crRNA3 described above.
[0020] In order to solve the above technical problems, the present invention also provides any of the following applications of the above-mentioned composition:
[0021] P1. Application in the development or preparation of products for detecting or assisting in the detection of Vibrio cholerae or its nucleic acid;
[0022] P2. Application in the development or preparation of products for screening or assisting in screening of cholera patients;
[0023] P3. Application in the development or preparation of screening or auxiliary screening of drugs for treating Vibrio cholerae.
[0024] The Vibrio cholerae mentioned above may be toxigenic Vibrio cholerae. The above product may be a product for distinguishing between non-toxigenic and toxigenic Vibrio cholerae.
[0025] The present invention relates to a CRISPR-Cas12a detection specific target sequence, a primer set and an application thereof for Vibrio cholerae, and more specifically to a primer, crRNA and an application thereof for detecting a target sequence and CRISPR-Cas12a for Vibrio cholerae. The object of the present invention is to provide a specific target sequence for nucleic acid detection of Vibrio cholerae and a CRISPR detection primer and crRNA targeting the sequence, and the primer set and crRNA are used in gene detection based on CRISPR technology to quickly detect Vibrio cholerae on site, and to distinguish between non-toxigenic and toxigenic Vibrio cholerae, with the advantages of good specificity, high sensitivity and simplicity.
[0026] The application of detecting Vibrio cholerae in the above text is a non-disease diagnosis and therapeutic application, and the method of detecting Vibrio cholerae in the above text is a non-disease diagnosis and therapeutic method; specifically, the application and method are intended to be used for the preparation of Vibrio cholerae drug models or for screening Vibrio cholerae therapeutic drugs.
[0027] The primers and crRNA provided by the present invention are related to in vitro diagnostic reagents in medical inspection and testing instruments and services, which are designed for the specific genes ompw and ctxa of Vibrio cholerae, and are detected using CRISPR (Clustered regularly interspaced short palindromic repeats) technology. In the CRISPR Cas system, the Cas protein, under the guidance of crRNA (CRISPR-derivedRNA), identifies the target sequence and initiates the "incidental cutting" activity. A fluorescent reporter molecule is added to the system, and the incidental cutting activity of the Cas enzyme is used to realize the conversion of the sequence information to be tested into a fluorescent signal. Through the coupling of RAA and Cas protein, a two-stage amplification of "sequence amplification" (completed by RAA) plus "enzymatic cascade" (completed by Cas enzyme) can be achieved, thereby surpassing the sensitivity of single-stage amplification such as Q-PCR. In addition, because the RAA amplification method does not require complex temperature changes, it is free from dependence on precision instruments such as Q-PCR instruments, making CRISPR-Cas technology have broad application prospects in the field diagnosis of Vibrio cholerae.
[0028] Experiments have shown that the CRISPR detection primers and crRNA provided by the present invention and the corresponding detection method have the characteristics of short detection time, high amplification efficiency, good sensitivity and strong specificity, and the detection sensitivity of the Vibrio cholerae genome can reach 1 copy / reaction, and the combination of a fluorescent flashlight can realize the visualized fluorescence detection of the experimental sample. The present invention has the characteristics of low cost, convenient operation, less time consumption, high sensitivity, strong specificity, simplicity and convenience, etc. The whole process is carried out in an environment of 37-40°C, which can effectively break away from the dependence on large laboratory instruments, and has broad application prospects in the field diagnosis of Vibrio cholerae. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] Figure 1 This is the result of Blast gene alignment.
[0030] Figure 2 Screening of crRNA for the ompw gene.
[0031] Figure 3 Screening of crRNA for the ctxa gene.
[0032] Figure 4 Screening of RAA primer pairs for ompw gene-1.
[0033] Figure 5 Screening of RAA primer pairs for ompw gene-2.
[0034] Figure 6 Screening of RAA primer pairs for ctxa gene-1.
[0035] Figure 7 Screening of RAA primer pairs for ctxa gene-2.
[0036] Figure 8 To evaluate the plasmid copy sensitivity of the CRISPR detection system for the ompw gene of Vibrio cholerae.
[0037] Fig. 9 To evaluate the plasmid copy sensitivity of the CRISPR detection system for the ctxa gene of Vibrio cholerae.
[0038] Fig.10 Visual fluorescence detection of the copy sensitivity experiment of the CRISPR detection system of the ompw gene of Vibrio cholerae.
[0039] Fig.11 Visual fluorescence detection for the copy sensitivity experiment of the CRISPR detection system of Vibrio cholerae ctxa gene.
[0040] Fig.12 To evaluate the specificity of the CRISPR detection system for the ompw gene of Vibrio cholerae.
[0041] Fig.13 To evaluate the specificity of the CRISPR detection system for the ctxa gene of Vibrio cholerae.
[0042] Fig.14 Visual fluorescence detection of the specificity experiment of the CRISPR detection system of the ompw gene of Vibrio cholerae.
[0043] Fig.15 Visual fluorescence detection of the CRISPR detection system specificity experiment of the Vibrio cholerae ctxa gene. DETAILED DESCRIPTION
[0044] The present invention is further described in detail below in conjunction with specific embodiments, and the examples provided are only for illustrating the present invention, rather than for limiting the scope of the present invention. The examples provided below can be used as a guide for further improvements by those of ordinary skill in the art, and do not constitute a limitation of the present invention in any way.
[0045] The experimental methods in the following examples, unless otherwise specified, are all conventional methods, and are performed according to the techniques or conditions described in the literature in the field or according to the product instructions. The materials, reagents, etc. used in the following examples, unless otherwise specified, can all be obtained from commercial channels.
[0046] The materials and instruments involved in the following examples are as follows:
[0047] RAA primers, crRNA and signal reporter probes were synthesized by Shanghai Sangon Biotechnology Co., Ltd., LbCas12a protein was from Nanjing GenScript Biotechnology Co., Ltd., NEBuffer TM r2.1 was purchased from New England Biolabs, and DEPC water was purchased from Bio-Technology Co., Ltd. The fluorescent RAA kit and common RAA reagent were purchased from Jiangsu Qitian Gene Biotechnology Co., Ltd. The positive reference plasmids for detection of Vibrio cholerae ompw and ctxa genes (pUC57-ompw, pUC57-ctxa) were synthesized and constructed by Suzhou Jinweizhi Biotechnology Co., Ltd. Other biochemical reagents were imported or domestic analytical grade.
[0048] Metal bath, centrifuge, vortexer, RAA-B6100 constant temperature oscillating mixer, RAA-F1620 isothermal amplification fluorescence detection system (Jiangsu Qitian Gene Biotechnology Co., Ltd.), LUYOR-3280 fluorescent flashlight (Shanghai Luyang Instrument Co., Ltd.), etc.
[0049] Example 1. Sequence design and establishment of CRISPR detection method for Vibrio cholerae
[0050] 1. Target sequence screening
[0051] The present invention obtains the reference genome sequences of Vibrio cholerae and other species of Vibrio through the NCBI database, and screens out the Vibrio cholerae specific gene ompw (CP043556.1REGION: complement (319187..319840)) (gene sequence as shown in SEQ ID No. 1) through MAUVE software comparison, and performs Blast sequence comparison on the NW91_03160 gene sequence. The comparison result is shown in FIG. Figure 1 As shown, there are 144 genomic sequences of Vibrio cholerae strains in the NCBI database. The ompw gene exists in all 144 Vibrio cholerae genomes and is specific only in Vibrio cholerae. As a specific conserved sequence of Vibrio cholerae, this sequence can specifically detect Vibrio cholerae. Suzhou Jinweizhi Biotechnology Co., Ltd. was commissioned to synthesize a plasmid (pUC57-ompw) containing this gene sequence.
[0052] Toxigenic Vibrio cholerae can secrete cholera toxin and cause severe diarrhea. The gene encoding cholera toxin comes from the ctxa gene of Vibrio phage CTXphi. The present invention obtains the cholera toxin gene ctxa (NC_015209REGION:8825..9601) encoded by Vibrio phage CTXphi through the NCBI database (the gene sequence is shown in SEQ ID No.2). This sequence is a specific conserved sequence of toxigenic Vibrio cholerae, and Vibrio cholerae that can encode cholera toxin can be specifically detected. Suzhou Jinweizhi Biotechnology Co., Ltd. was commissioned to synthesize a plasmid (pUC57-ctxa) containing the gene sequence.
[0053] SEQ ID No.1(5'-3'):
[0054] .
[0055] SEQ ID No.2(5'-3')
[0056] .
[0057] 2. Design of amplification primer pairs, crRNA and probes
[0058] For the above-mentioned Vibrio cholerae-specific gene ompw sequence (as shown in SEQ ID No.1) and the toxigenic Vibrio cholerae-specific gene ctxa (as shown in SEQ ID No.2), RAA amplification primer pairs, fluorescent probes (Table 1), crRNA and probes (Table 2) were designed, and the sequences are shown in Tables 1 and 2.
[0059] Table 1. Candidate RAA amplification primer pairs and fluorescent probes of the present invention
[0060]
[0061] Table 2. Candidate crRNA sequences and probes of the present invention
[0062]
[0063]
[0064] Note: The underlined sequence in ompW-CrRNA10 is the guide sequence (matching the sequence of the amplified product of the RAA primer pair, nucleotides 22-42 of SEQ ID No.40), and the sequence before the underline is the anchor sequence (nucleotides 1-21 of SEQ ID No.40, used to bind to the cas protein). The underlined sequence in ctxA-CrRNA3 is the guide sequence (matching the sequence of the amplified product of the RAA primer pair, nucleotides 22-41 of SEQ ID No.23), and the sequence before the underline is the anchor sequence (nucleotides 1-21 of SEQ ID No.23, used to bind to the cas protein). The 5' terminal base (nucleotide 1) of the Probe sequence shown in SEQ ID No.42 is labeled with FAM, and the quencher group BHQ1 is labeled at the 3' end (nucleotide 12).
[0065] 3. CRISPR detection reaction principle
[0066] Principle of CRISPR experiment: crRNA combines with LbCas12a to form a complex, which can specifically recognize the DNA sequence complementary to crRNA. The LbCas12a enzyme is activated and begins to cut the single-stranded DNA probe in the reaction system. The probe is composed of a fluorescent group and a quenching group connected by several bases. After the probe is cut, fluorescence is generated, indicating that the reaction system contains the target gene, which plays an identification role.
[0067] 4. Establishment of CRISPR detection method
[0068] 4.1 RAA amplification
[0069] The nucleic acid of the sample to be tested is used as a template and amplified using RAA amplification primers to obtain RAA amplification products.
[0070] The RAA reaction premix solution is (44 μL): RAA amplification buffer (Qitian Gene, B00000A, provided by the regular RAA kit) 25 μL, 10 μM upstream primer 2 μL, 10 μM downstream primer 2 μL and purified water 15 μL.
[0071] After the RAA reaction premix is prepared, add 44 μL of the above reaction solution to each reaction unit of the RAA kit and dissolve evenly, add 1 μL of the nucleic acid of the sample to be tested, add 5 μL of MgAc in the tube cap, put it into the RAA-B6100 instrument, set the reaction temperature to 37°C, and the time to 30 min (1800 s).
[0072] 4.2 CRISPR cleavage
[0073] The RAA amplification product is cleaved under the action of crRNA and LbCas12a protein, and the probe is used as a fluorescent signal to obtain a cleavage reaction product.
[0074] The reaction system for the cleavage reaction is: NEBuffer TM r2.1 2 μL, 26 μM LbCas12a protein diluted 26 times and 1 μL (the final concentration in the system is 50 nM), 10 μM specific crRNA 1 μL (the final concentration in the system is 500 nM), 10 μM probe diluted 5 times and 1 μL (the final concentration in the system is 100 nM), DEPC water 10 μL and RAA amplification product obtained in step 4.1 5 μL.
[0075] The cleavage reaction was carried out by incubation at 37°C for 20 minutes to obtain a reaction product.
[0076] 4.3 Detection
[0077] (1) Fluorescence detector
[0078] The cleavage reaction product was detected by a fluorescence detector, and the fluorescence value was read every 20 seconds. The cumulative fluorescence value was used as the signal intensity, and the analysis and judgment were performed according to the following standards:
[0079] If the fluorescence amount (fluorescence value) of the reaction product is less than or equal to twice the fluorescence amount of the negative control, the sample to be tested does not contain or the candidate does not contain Vibrio cholerae or its nucleic acid;
[0080] If the fluorescence of the reaction product is greater than twice that of the negative control, the sample to be tested contains or is a candidate for containing Vibrio cholerae or its nucleic acid.
[0081] The negative control group is a negative control set corresponding to each experimental group, in which water or other non-Vibrio cholerae DNA (such as water) is added as a template.
[0082] (2) Visual judgment
[0083] The reaction product was illuminated by a portable fluorescent flashlight with a fluorescence emission wavelength of OD 440nm -OD 460nm .
[0084] If the reaction product fluoresces, the sample to be tested contains or is a candidate for containing Vibrio cholerae or its nucleic acid;
[0085] If the reaction product does not fluoresce, the sample to be tested does not contain or is likely to contain Vibrio cholerae or its nucleic acid.
[0086] Example 2: Screening of crRNA in CRISPR Detection Reaction
[0087] crRNA was designed for the ompw and ctxa gene sequences, respectively. The crRNA leader sequence was designed downstream of the PAM sequence containing TTTN (there is a 5'-TTTN-3' PAM sequence in the RAA amplification product sequence, and N is A, C or G), and an anchor sequence was added upstream of the leader sequence. Ten crRNA sequences for the ctxa gene (SEQ ID No.21-SEQ IDNo.30 in Table 1) and 11 crRNA sequences for the ompw gene (SEQ ID No.31-SEQ ID No.41 in Table 1) were designed, respectively.
[0088] Experimental group: CRISPR reaction system: NEBuffer TM r2.1 (New England Biolabs, B6002S) 2 μL, 26 μM LbCas12a protein (GenScript, Z03753) was diluted 26 times and then 1 μL was taken (the final concentration in the system was 50 nM), 10 μM specific crRNA (any one of SEQ ID NO.21-SEQ ID NO.41) was taken 1 μL (the final concentration in the system was 500 nM), 10 μM probe (SEQ ID NO.42) was diluted 5 times and then 1 μL was taken (the final concentration in the system was 100 nM), DEPC water 14 μL, and the concentration of ompw and ctxa plasmids synthesized in step 1 of Example 1 was 50 nM each. The reaction system was placed at 37 ° C for 30 min, and the fluorescence value was detected in real time using RAA-F1620 instrument. The negative control group replaced the template with 1 μL DEPC water.
[0089] The gene-synthesized ompw plasmid (pUC57-ompw) is a recombinant vector obtained by replacing the small fragment between the BamHI and HindIII restriction sites of the pUC57 vector (Suzhou Jinweizhi Biotechnology Co., Ltd.) with the gene fragment shown in SEQ ID NO.1 and keeping the other sequences of the pUC57 vector unchanged. The gene-synthesized ctxa plasmid (pUC57-ompw) is a vector obtained by replacing the small fragment between the BamHI and HindIII restriction sites of the pUC57 vector (Suzhou Jinweizhi Biotechnology Co., Ltd.) with the gene fragment shown in SEQ ID NO.2 and keeping the other sequences of the pUC57 vector unchanged.
[0090] The results of the 10 crRNA sequences targeting the ompw gene are as follows: Figure 2 As shown in Table 1, ompw-CrRNA10 ( Figure 2 The expression of crRNA 10 in the experiment group was the best, and the slope ratio of the fluorescence curves of the experimental group and the negative control group was the largest, which was 148.
[0091] The results of 11 crRNA sequences targeting ctxa gene are as follows Figure 3 As shown in Table 1, ctxa-CrRNA3 ( Figure 3 The expression of crRNA3 in the experiment group was the best, and the slope ratio of the fluorescence curves of the experimental group and the negative control group was the largest, which was 154.
[0092] Therefore, the present invention selects ompw-CrRNA10 as the CrRNA for detecting Vibrio cholerae, and selects ctxa-CrRNA3 as the CrRNA for toxigenic Vibrio cholerae.
[0093] Example 3: Screening of RAA amplification primers for Vibrio cholerae
[0094] The synthesized ompw plasmid (pUC57-ompw) and ctxa plasmid (pUC57-ctxa) stock solutions were diluted 10-fold to 1000 copies / μL, and the gradient dilutions were used as templates for amplification according to the RAA method: 1 μL of the 1000 copies / μL plasmid dilution template was taken for RAA amplification, and 1 μL H2O was used as a template as a negative control. The RAA amplification reaction was performed according to the Qitian Gene RAA Kit (Cat. No.: F00000A) to prepare the premix.
[0095] The RAA premix system is: buffer (Qitian, F00000A, provided by the fluorescent RAA kit) 25 μL, 10 μM upstream primer (ompw gene is any one of SEQ ID NO.3-SEQ ID NO.6 in Table 1, ctxa gene is any one of SEQ ID NO.11-SEQ ID NO.14 in Table 1) 2.1 μL, 10 μM downstream primer (ompw gene is any one of SEQ ID NO.7-SEQ ID NO.10 in Table 1, ctxa gene is any one of SEQ ID NO.15-SEQ ID NO.18 in Table 1) 2.1 μL, 10 μM probe (ompw gene is SEQ ID NO.19 in Table 1, ctxa gene is SEQ ID NO.20 in Table 1, the function of which is to bind to the target gene fragment, emit fluorescence, and indicate the gene amplification situation) 0.6 μL, and 14.2 μL of water.
[0096] After the premix is prepared, add 44 μL of the premix to each tube of the basic reaction unit in the fluorescent RAA kit (which comes with the kit and contains a recombinase that can bind to single-stranded nucleic acids, a single-stranded DNA binding enzyme, a strand-displacing DNA polymerase, dNTPs, etc.) and dissolve evenly. Add 1 μL (1×10 3 5 μL MgAc was pipetted onto the RAA tube cap, placed into RAA-B6100, and the pre-treatment key was pressed for pre-amplification. After the instrument beeps, the reaction tube was taken out and placed into the RAA-F1620 instrument. The instrument was set to a reaction temperature of 39°C and a reaction time of 20 min (1200 s), and fluorescence was detected in real time.
[0097] The screening results of RAA amplification primers for ompw gene are as follows Figure 4 and Figure 5 As shown, the fluorescence value of the RAA amplification primer pair ompw-3F / ompw-1R of the ompw gene in the 20-min period 3F+1R ( Figure 5 The 3F-1R combination is much larger than other combinations and has significant differences from other primer sets. The screening results of RAA amplification primers for ctxa gene are shown in Figure 6 and Figure 7 As shown, the fluorescence value of 2F+1R of the RAA amplification primer pair ctxa-2F / ctxa-1R of the ctxa gene in the 20-min period ( Figure 7 The 2F-1R combination is much larger than other combinations and has significant differences from other primer sets.
[0098] Therefore, the present invention selects ompw-3F / ompw-1R as the RAA detection primer pair for detecting Vibrio cholerae, and selects ctxa-2F / ctxa-1R as the RAA detection primer pair for detecting toxigenic Vibrio cholerae.
[0099] Example 4. Determination of the sensitivity of the Vibrio cholerae CRISPR detection system
[0100] 1. RAA amplification reaction
[0101] The ompw plasmid (pUC57-ompw) and ctxa plasmid (pUC57-ompw) stock solutions were diluted 10-fold in a gradient dilution solution (1×10 2 copies / μL, 1×10 1 copies / μL, 1×10 0 The specific RAA primer pairs ompw-3F / ompw-1R and ctxa-2F / ctxa-1R obtained in Example 3 were used to perform RAA amplification reaction according to the Qitian RAA kit (Cat. No.: B00000A), and the recombinase polymerase amplification reaction technique (RAA) reaction was performed to obtain RAA amplification products. Water was used as a template as a negative control.
[0102] The RAA reaction premix solution is: RAA amplification buffer (Qitian, B00000A, provided by the ordinary RAA kit) 25 μL, 10 μM upstream primer 2 μL, 10 μM downstream primer 2 μL and water 15 μL.
[0103] After the RAA reaction premix was prepared, 44 μL of the above reaction solution was added to each reaction unit of the RAA kit and dissolved evenly, 1 μL of plasmids of different concentrations were added respectively, 5 μL MgAc was added to the tube cap, and the instrument was placed in the RAA-B6100 instrument, and the reaction temperature was set to 37°C and the time was 30 min (1800 s).
[0104] 2. Cas12a cleavage reaction
[0105] The specific ompw-CrRNA10 (SEQ ID NO.40) and ctxa-CrRNA3 (SEQ ID NO.23) obtained in Example 2 were respectively used to guide LbCas12a protein (GenScript Biotech Co., Ltd., Z03753) to incubate the RAA amplification product obtained in step 1 at 37 ° C for 20 minutes for cleavage reaction to obtain a reaction product.
[0106] The reaction system for the cleavage reaction is: NEBuffer TMr2.1 2 μL, 26 μM LbCas12a protein was diluted 26 times and 1 μL was taken (the final concentration in the system was 50 nM), 10 μM specific crRNA was taken 1 μL (the final concentration in the system was 500 nM), 10 μM probe (SEQ ID NO: 42) was diluted 5 times and 1 μL was taken (the final concentration in the system was 100 nM), DEPC water 10 μL and RAA amplification product obtained in step 1 5 μL.
[0107] 3. Sensitivity detection
[0108] 3.1 Fluorescence detector
[0109] The reaction product obtained in step 2 was placed in the RAA-F1620 instrument. The instrument was set to a reaction temperature of 37° C., a reaction time of 20 min (1200 s), and fluorescence was detected in real time.
[0110] The results are as follows Figure 8 As shown, 1 copy / tube ( Figure 8 1), 10 copies / tube ( Figure 8 10), 100 copies / tube ( Figure 8 In Chinese: 10 2 ) correspond to 1, 10, 1×10 2 The ompw-CrRNA10-Cas12a combined reaction detection method was used to detect the ompw gene with a sensitivity of 1 copy / μL. The ompw-3F / ompw-1R primer pair was used for RAA amplification, and the product of RAA amplification was used as the target DNA. The sensitivity of the ompw-CrRNA10-Cas12a combined reaction detection for the ompw gene was 1 copy / reaction.
[0111] The results are as follows Fig. 9 As shown, 1 copy / tube ( Fig. 9 1), 10 copies / tube ( Fig. 9 10), 100 copies / tube ( Fig. 9 In Chinese: 10 2 ) correspond to 1, 10, 1×10 2 The sensitivity of ctxa-CrRNA3-Cas12a combined reaction detection for ctxa gene was 1 copy / reaction.
[0112] 3.2 Visual inspection
[0113] Use a LUYOR-3280 fluorescent flashlight to visualize the fluorescence of the eight-tube reaction product obtained in step 2 and take photos.
[0114] ompw gene results Fig.10 As shown, sample 0 is the negative control, and sample 1 corresponds to 1 copy / μL of template DNA ( Fig.10 denoted as 1), 10 corresponds to 10 copies / μL of template DNA ( Fig.10 10), 100 corresponds to 100 copies / μL of template DNA ( Fig.10 It can be seen that the ompw plasmid (pUC57-ompw) containing 1, 10, and 100 copies has obvious fluorescence compared with the negative control group.
[0115] ctxa gene results Fig.11 As shown, sample 0 is the negative control, and sample 1 corresponds to 1 copy / μL of template DNA ( Fig.11 denoted as 1), 10 corresponds to 10 copies / μL of template DNA ( Fig.11 10), 100 corresponds to 100 copies / μL of template DNA ( Fig.11 It can be seen that the ctxa plasmid (pUC57-ctxa) containing 1, 10, and 100 copies has obvious fluorescence compared with the negative control group.
[0116] Example 5. Specificity detection of Vibrio cholerae CRISPR detection system
[0117] The specificity of the Vibrio cholerae detection method of the present invention was evaluated using the Vibrio cholerae genomic nucleic acid template, the genomic nucleic acid templates of 6 pathogenic bacteria and deionized water as negative controls. The 6 pathogenic bacteria include Staphylococcus aureus, Bacillus cereus, Escherichia coli, Vibrio parahaemolyticus, Salmonella and hemolytic Streptococcus.
[0118] First, RAA amplification was performed on the genome of each test bacteria using primers ompw-3F / ompw-1R and ctxa-2F / ctxa-1R, respectively, to obtain RAA amplification product 1 for ompw detection and RAA amplification product 2 for ctxa detection; then, the ompw-CrRNA10-Cas12a combination reaction was used to perform CRISPR detection reaction for RAA amplification product 1 for specificity analysis, and the ctxa-CrRNA3-Cas12a combination reaction was used to perform CRISPR detection reaction for RAA amplification product 2 for specificity analysis.
[0119] The details are as follows:
[0120] 1. RAA amplification reaction
[0121] The genomic DNA of the following strains stored in the laboratory was used: Vibrio parahaemolyticus (S251), Streptococcus pyogenes (ATCC1059), Staphylococcus aureus (ATCC6538), Escherichia coli (O157:H7), Bacillus cereus (17003-25), Salmonella (S.ty2) and Vibrio cholerae (O1).
[0122] Vibrio parahaemolyticus (S251) is described in the following literature, where it is called Vibrio parahaemolyticus (S251 strain): Comparison of enterotoxicity, cytotoxicity and hemolytic activity of two standard strains of Vibrio parahaemolyticus, Chinese Journal of Clinical Physicians (Electronic Edition), 2013, 007(006): 154-15.
[0123] Hemolytic Streptococcus (ATCC1059) is described in the following literature, where its name is Streptococcus hemolytic-β (ATCC1059): Rapid detection of group A beta-hemolytic Streptococcus by recombinase-mediated amplification, Chinese Journal of Frontier Health and Quarantine, 2018, 41(5): 314-323.
[0124] Staphylococcus aureus (ATCC6538) is described in the following literature, where its name is Staphylococcus aureus (ATCC6538): Rapid Detection of Group A Beta-Hemolytic Streptococci by Recombinase-Mediated Amplification, Chinese Journal of Frontier Health and Quarantine, 2018, 41(5): 314-323.
[0125] Escherichia coli (O157:H7) is described in the following literature and is referred to as O157:H7: Zhao Y, Li Y, Zhang P, et al. Cell-based fluorescent microsphere incorporated with carbon dots as a sensitive immunosensor for the rapid detection of Escherichia coli O157 in milk. Biosens Bioelectron. 2021 May 1; 179: 113057. doi: 10.1016 / j.bios.2021.113057. Epub 2021 Feb 2.
[0126] Bacillus cereus (17003-25) is described in the following literature, where its name is Bacillus cereus (17003-25): Differentiation of Anthrax and Bacillus cereus by Amplified Fragment Length Polymorphism Analysis, Biotechnology Letters, 2012, 23(4): 546-549.
[0127] Salmonella (S.ty2) is described in the following literature, where its name is Salmonella typhi (S.ty2): Knockout of rfaH gene of Salmonella typhi using λRed recombination system, Biotechnology Letters, 2009, 20(2): 173-176.
[0128] Vibrio cholerae (O1) is recorded in the following literature, where its name is Vibrio cholerae O1 Chinese isolate: Establishment of a multiplex PCR detection method for Vibrio cholerae and enterohemorrhagic Escherichia coli, Chinese Journal of Veterinary Science, 2012, 32(10): 1507-1510.
[0129] Using the genomic DNA of each strain as a template, RAA amplification reaction was performed according to the method of step 1 of the above embodiment 4 to obtain amplification products.
[0130] 2. Cas12a cleavage reaction
[0131] The cleavage reaction was carried out according to the method of step 2 of the above embodiment 4 to obtain a reaction product.
[0132] 3. Detection
[0133] 1) Fluorescence detector
[0134] The reaction product obtained in step 2 was placed in the RAA-F1620 instrument. The instrument was set to a reaction temperature of 37° C., a reaction time of 20 min (1200 s), and fluorescence was detected in real time.
[0135] The results are as follows Fig.12 and Fig.13 As shown, it can be seen that the Vibrio cholerae CRISPR detection system established by the present invention has good specificity and can only detect Vibrio cholerae, and has no cross reaction with engineered bacteria such as Vibrio parahaemolyticus, hemolytic Streptococcus, Staphylococcus aureus, Escherichia coli, Bacillus cereus, and Salmonella.
[0136] 2) Visual inspection
[0137] Use a portable fluorescent flashlight to perform visual fluorescence detection on the eight-tube reaction product obtained in step 2.
[0138] The results are as follows Fig.13 and Fig.14 As shown, only the sample containing the V. cholerae genome had significant fluorescence.
[0139] The present invention has been described in detail above. For those skilled in the art, without departing from the purpose and scope of the present invention, and without the need to carry out unnecessary experimental conditions, the present invention can be implemented in a wide range under equivalent parameters, concentrations and conditions. Although the present invention provides specific embodiments, it should be understood that the present invention can be further improved. In a word, according to the principles of the present invention, the application is intended to include any changes, uses or improvements to the present invention, including departure from the disclosed scope in the application, and changes made with conventional techniques known in the art.
Claims
1. A kit for detecting Vibrio cholerae, wherein the kit is kit A, kit B or kit C; The kit A contains an ompw-3F / ompw-1R primer pair, a ctxa-2F / ctxa-1R primer pair, a Probe, an ompw-crRNA10 and a ctxa-crRNA3; the ompw-3F / ompw-1R primer pair consists of an ompw-3F primer and an ompw-1R primer, the ompw-3F primer is a single-stranded DNA molecule shown in SEQ ID No.5 in the sequence list, and the ompw-1R primer is a single-stranded DNA molecule shown in SEQ ID No.7 in the sequence list; the ctxa-2F / ctxa-1R primer pair consists of a ctxa-2F primer and a ctxa-1R primer, the ctxa-2F primer is a single-stranded DNA molecule shown in SEQ ID No.12 in the sequence list, and the ctxa-1R primer is a single-stranded DNA molecule shown in SEQ ID No.15 in the sequence list; the Probe is a single-stranded DNA molecule shown in SEQ ID No. The single-stranded DNA molecule shown in No.42, the ompw-crRNA10 is the RNA molecule shown in SEQ ID No.40 in the sequence list, and the ctxa-crRNA3 is the RNA molecule shown in SEQ ID No.23 in the sequence list; The kit B contains an ompw-3F / ompw-1R primer pair, a Probe and an ompw-crRNA10; the ompw-3F / ompw-1R primer pair consists of an ompw-3F primer and an ompw-1R primer, the ompw-3F primer is a single-stranded DNA molecule shown in SEQ ID No.5 in the sequence list, and the ompw-1R primer is a single-stranded DNA molecule shown in SEQ ID No.7 in the sequence list; the Probe is a single-stranded DNA molecule shown in SEQ ID No.42 in the sequence list, and the ompw-crRNA10 is an RNA molecule shown in SEQ ID No.40 in the sequence list; The kit C contains a ctxa-2F / ctxa-1R primer pair, a Probe and a ctxa-crRNA3; the ctxa-2F / ctxa-1R primer pair consists of a ctxa-2F primer and a ctxa-1R primer, the ctxa-2F primer is a single-stranded DNA molecule shown in SEQ ID No.12 in the sequence list, and the ctxa-1R primer is a single-stranded DNA molecule shown in SEQ ID No.15 in the sequence list; the Probe is a single-stranded DNA molecule shown in SEQ ID No.42 in the sequence list, and the ctxa-crRNA3 is an RNA molecule shown in SEQ ID No.23 in the sequence list.
2. The kit according to claim 1, characterized in that The Probe is labeled with a fluorescent group on the 1st nucleotide of SEQ ID No.42 and a quenching group BHQ1 on the 12th nucleotide.
3. The kit according to claim 1 or 2, characterized in that: The kit also contains Cas12a protein.
4. The kit according to claim 1, 2 or 3, characterized in that: The kit also includes a recombinant vector containing an ompw gene sequence whose nucleotide sequence is SEQ ID No. 1 and / or a recombinant vector containing a ctxa gene sequence whose nucleotide sequence is SEQ ID No.
2.
5. The kit according to any one of claims 1 to 4, characterized in that: The ompw-crRNA10 consists of a guide sequence and an anchor sequence; the guide sequence is the 22nd to 42nd nucleotides of SEQ ID No.40 in the sequence list; the anchor sequence is the 1st to 21st nucleotides of SEQ ID No.26 in the sequence list; the ctxa-crRNA3 consists of a guide sequence and an anchor sequence; the guide sequence is the 22nd to 41st nucleotides of SEQ ID No.23 in the sequence list; the anchor sequence is the 1st to 21st nucleotides of SEQ ID No.23 in the sequence list.
6. The kit according to any one of claims 1 to 5, characterized in that: The kit also contains an RNase inhibitor.
7. A system for detecting genomic DNA of Vibrio cholerae, characterized in that: The system comprises the kit according to any one of claims 1 to 6.
8. The system according to claim 7, characterized in that: The system also contains a fluorescence detection system.
9. A composition, characterized in that: The composition is composition A-1, composition B-1 or composition C-1; The composition A-1 contains the ompw-3F / ompw-1R primer pair, ctxa-2F / ctxa-1R primer pair, Probe, ompw-crRNA10 and ctxa-crRNA3 described in claim 1 or 2; The composition B-1 contains the ompw-3F / ompw-1R primer pair, Probe and ompw-crRNA10 described in claim 1 or 2; The composition C-1 contains the ctxa-2F / ctxa-1R primer pair, Probe and ctxa-crRNA3 described in claim 1 or 2.
10. The composition of claim 9 for use in any of the following: P1. Application in the development or preparation of products for detecting or assisting in the detection of Vibrio cholerae or its nucleic acid; P2. Application in the development or preparation of products for screening or assisting in screening of cholera patients P3. Application in the development or preparation of screening or auxiliary screening of drugs for treating Vibrio cholerae;.
